Crossmatch is seeking a variety of relief from the court including a permanent injunction prohibiting Integrated Biometrics’ sale of infringing products, as well as monetary damages, including treble damages for willful infringement and recovery of attorneys’ fees.

“Our technologies and expertise are helping organizations of all sizes achieve enhanced levels of security and efficiency,” explained Crossmatch General Counsel Kathryn Hutton. “As a successful innovator in a critical area of national and personal security, we will forcefully defend our intellectual property and take action against those who violate it.”

In an email, Integrated Biometrics CEO Steve Thies commented, “While we acknowledge CMT has sued IB for patent infringement, we want the biometric market to know that IB plans to defend vigorously against the allegations. IB’s unique and patented products are meeting the needs of customers world-wide. IB believes that CMT is trying to disrupt IB’s success in the market place.”

This article was updated at 12:15 EDT on May 4, 2017 with comments from Integrated Biometrics CEO Steve Thies.